NCT06161896View on ClinicalTrials.gov

Characterization and Clinical Impact of the Gut Microbiota in Lymphoma

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 6, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DIAGNOSTIC_TEST

Stool samples

Analysis of microbiome, mutations, alterations in body composition and lifestyle

Trial Locations (1)

4000

RECRUITING

Zealand University Hospital, Department of Hematology, Roskilde

All Listed Sponsors
collaborator

Zealand University Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Statens Serum Institut

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

lead

Lars Møller Pedersen

OTHER